Soluble Fn14 Is Detected and Elevated in Mouse and Human Kidney Disease

Autor: Shawn P. O'Neil, Gabriela Campanholle, Eva E. Nagiec, Bruce L. Homer, Lih-Ling Lin, Hendrik Neubert, Karrie A. Brenneman, Ju Wang, Margaret Fleming, Steven Evans, Riyez Karim, Yutian Zhan, Priya S. Chockalingam, Nicholas Pullen, M Nusrat Sharif, Jameel Syed
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Male
B Vitamins
Physiology
Protein Expression
Lupus nephritis
lcsh:Medicine
Urine
Kidney
Receptors
Tumor Necrosis Factor

Diabetic nephropathy
Mice
Tandem Mass Spectrometry
Medicine and Health Sciences
lcsh:Science
Cytokine TWEAK
Multidisciplinary
Proteinuria
Nephritis
Organic Compounds
Acute kidney injury
Animal Models
Vitamins
Acute Kidney Injury
Lupus Nephritis
Up-Regulation
Body Fluids
Chemistry
medicine.anatomical_structure
TWEAK Receptor
Nephrology
Reperfusion Injury
Physical Sciences
Kidney Diseases
medicine.symptom
Anatomy
Research Article
Adult
Mouse Models
Research and Analysis Methods
03 medical and health sciences
Folic Acid
Model Organisms
medicine
Gene Expression and Vector Techniques
Animals
Humans
Animal Models of Disease
Molecular Biology Techniques
Immunohistochemistry Techniques
Molecular Biology
Molecular Biology Assays and Analysis Techniques
030102 biochemistry & molecular biology
business.industry
Organic Chemistry
lcsh:R
Chemical Compounds
Kidney metabolism
Biology and Life Sciences
Kidneys
Renal System
medicine.disease
Histochemistry and Cytochemistry Techniques
Disease Models
Animal

030104 developmental biology
Solubility
Immunology
Immunologic Techniques
Animal Studies
lcsh:Q
business
Kidney disease
Chromatography
Liquid
Zdroj: PLoS ONE, Vol 11, Iss 5, p e0155368 (2016)
PLoS ONE
ISSN: 1932-6203
Popis: The cytokine TWEAK and its cognate receptor Fn14 are members of the TNF/TNFR superfamily and are upregulated in tissue injury to mediate local tissue responses including inflammation and tissue remodeling. We found that in various models of kidney disease, Fn14 expression (mRNA and protein) is upregulated in the kidney. These models include: lupus nephritis mouse models (Nephrotoxic serum Transfer Nephritis and MRL.Faslpr/lpr), acute kidney injury models (Ischemia reperfusion injury and Folic acid injury), and a ZSF-1 diabetic nephropathy rat model. Fn14 expression levels correlate with disease severity as measured by disease histology. We have also shown for the first time the detection of soluble Fn14 (sFn14) in the urine and serum of mice. Importantly, we found the sFn14 levels are markedly increased in the diseased mice and are correlated with disease biomarkers including proteinuria and MCP-1. We have also detected sFn14 in human plasma and urine. Moreover, sFn14 levels, in urine are significantly increased in DN patients and correlated with proteinuria and MCP-1 levels. Thus our data not only confirm the up-regulation of Fn14/TWEAK pathway in kidney diseases, but also suggest a novel mechanism for its regulation by the generation of sFn14. The correlation of sFn14 levels and disease severity suggest that sFn14 may serve as a potential biomarker for both acute and chronic kidney diseases.
Databáze: OpenAIRE